- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Immunomedics shows improvement
Radiopharmaceutical developer Immunomedics is beginning to show some results from its restructuring and the refocusing of its operations (SCAN 4/28/99). The Morris Plains, NJ-based company reported a 28.6% increase in its fourth-quarter revenues
Radiopharmaceutical developer Immunomedics is beginning to show some results from its restructuring and the refocusing of its operations (SCAN 4/28/99). The Morris Plains, NJ-based company reported a 28.6% increase in its fourth-quarter revenues (end-June). Revenues were $1.8 million, compared with the $1.4 million reported in the same quarter a year ago. The firms net loss also narrowed to $2.6 million, compared with a loss of $3.4 million in the fourth quarter last year.
The improved fourth quarter results werent enough to buoy the firm to an improved performance for the year, however. For 1998, revenues were $7.6 million, showing no growth over the $7.6 million posted last year. The firm trimmed its losses slightly, however, recording a net loss of $11.2 million, compared with $11.8 million in fiscal 1998.
In other Immunomedics news, vice president for global marketing and business development Philippe Barzin has left the company. The firm had announced just last month that Barzin, formerly general manager, was relocating to the U.S. to assume his new post (SCAN 8/4/99). In the meantime, Joop Meijer has taken over for Barzin in Europe as general manager of Immunomedics BV, which manages marketing and sales of the companys CEA-Scan and LeukoScan imaging agents in Europe. Meijer previously held sales and marketing positions at Mallinckrodt and ADAC Laboratories.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
